Topics

Gliomas | Treatment | Targeted therapy | Evolocumab

Home > Publications > Topics > Gliomas > Treatment > Targeted therapy > Evolocumab

Singh K, Foster MW, Violette MJ, Corcoran AM, Hotchkiss KM, Railton CO, Blandford EE, Blethen KE, Thomas EL, McIntosh WC, Ashley DM, Desjardins A, Friedman HS, Johnson MO, Friedman A, Keir S, Buckley ED, Herndon JE, McLendon RE, Sampson JH, Calabrese E, López GY, Grant GA, Patel AP, Gregory SG, Li CY, Fecci PE, Khasraw M.
A surgical window of opportunity trial evaluating the effect of the PCSK9 inhibitor evolocumab on tumoral MHC-I expression and CD8⁺ infiltration in glioma.
Sci Rep. 2025 Oct 23;15(1):37112. doi: 10.1038/s41598-025-21064-9. PMID: 41131134. Interventional study. ˍ